Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021;10(1):2.
doi: 10.1186/s43088-020-00089-1. Epub 2021 Jan 11.

Chemical profiling of selected Ayurveda formulations recommended for COVID-19

Affiliations

Chemical profiling of selected Ayurveda formulations recommended for COVID-19

Sulaiman C T et al. Beni Suef Univ J Basic Appl Sci. 2021.

Abstract

Background: The novel coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), is the global health concern since December 2019. It has become a big challenge for the researchers to find a solution for this newly evolved pandemic. In Ayurveda point of view, COVID-19 is a Janapadodhwamsa vikara (epidemic disease), a situation where the environment-air, water, land, and seasons-is vitiated, causing a simultaneous manifestation of a disease among large populations. The aim of this study is to identify the active compounds of selected Ayurveda medicines recommended for COVID-19.

Results: The selected preparations are traditionally recommended for the management of various kinds of fever including the infectious ones and to enhance the immunity. HPTLC analysis of the same showed presence of many active molecules like umbelliferone, scopoletin, caffeic acid, ferulic acid, gallic acid, piperine, curcumin, berberine, and palmatine.

Conclusion: The study provided valuable scientific data regarding the active ingredients of the selected medicines with proven therapeutic potentials like anti-viral, immunomodulatory, and anti-inflammatory activities.

Keywords: Ayurveda; COVID-19; HPTLC; Indukantham Kwatham; Mukkamukkatuvadi Gulika; Vilvadi Gulika.

PubMed Disclaimer

Conflict of interest statement

Competing interestsThe authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
HPTLC profiling of IK, MMG, and VG documented at UV-254, 366, and visible light

References

    1. Chitranshi N, Gupta VK, Rajput R, Godinez A, Pushpitha K, Shen T, Mirzaei M, You Y, Basavarajappa D, Gupta V, Graham SL. Evolving geographic diversity in SARS-CoV2 and in silico analysis of replicating enzyme 3CLpro targeting repurposed drug candidates. J Transl Med. 2020;18:278. doi: 10.1186/s12967-020-02448-z. - DOI - PMC - PubMed
    1. Chen H, Guo J, Wang C, Luo F, Yu X, Zhang W, Li J, Zhao D, Xu D, Gong Q. Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records. Lancet. 2020;395:809–815. doi: 10.1016/S0140-6736(20)30360-3. - DOI - PMC - PubMed
    1. Girija LT, Sivan N (2020) Ayurveda treatment of COVID-19/ SARS-CoV-2: a case report. J Ayu Int Med. 10.1016/j.jaim.2020.06.001 - PubMed
    1. Venkateswaran PS, Millman I, Blumberg BS. Effects of an extract from Phyllanthus niruri on hepatitis B and woodchuck hepatitis viruses: in vitro and in vivo studies. Proc Natl Acad Sci U S A. 1987;84:274–278. doi: 10.1073/pnas.84.1.274. - DOI - PMC - PubMed
    1. Hudson JB. Antiviral compounds from plants. Boca Raton, Ann Arbor, Boston: CRC Press; 1990.

LinkOut - more resources